Abstract

The Project Leaders of the Emory/Children's TRC-THD Center application are basic, translational and clinical research scientists who have a strong interest in hemostasis and thrombosis. The Aflac Cancer Center and Blood Disorders Service Hemostasis and Thrombosis Program (Aflac HT Program) includes three young faculty investigators, Shannon Meeks, M.D., Wilbur Lam, M.D., Ph.D., and Amy Dunn, M.D., who will advance to more senior status by enhancing their research skills as Project Leaders. Additionally, the Aflac HT Program includes a young clinician scientist. Ana Antun, M.D., who recently completed her fellowship training in hematology and will enter the ACTSI MSCR program. Additionally, the Aflac HT Program has an extensive history of training medical students, Ph.D. and M.D./Ph.D. graduate students and clinical fellows and will continue to expand in this area as it continues to grow.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54HL112309-02
Application #
8464239
Study Section
Special Emphasis Panel (ZHL1-CSR-C)
Project Start
Project End
Budget Start
2013-05-01
Budget End
2014-04-30
Support Year
2
Fiscal Year
2013
Total Cost
$121,647
Indirect Cost
$33,878

  Institution

Name
Emory University
Department
Type
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322

  Publications

Brown, Harrison C; Zakas, Philip M; George, Stephan N et al. (2018) Target-Cell-Directed Bioengineering Approaches for Gene Therapy of Hemophilia A. Mol Ther Methods Clin Dev 9:57-69
Zhang, Yun; Qiu, Yongzhi; Blanchard, Aaron T et al. (2018) Platelet integrins exhibit anisotropic mechanosensing and harness piconewton forces to mediate platelet aggregation. Proc Natl Acad Sci U S A 115:325-330
Healey, J F; Parker, E T; Lollar, P (2018) Identification of aggregates in therapeutic formulations of recombinant full-length factor VIII products by sedimentation velocity analytical ultracentrifugation. J Thromb Haemost 16:303-315
Batsuli, G; Ito, J; Mercer, R et al. (2018) Anti-C1 domain antibodies that accelerate factor VIII clearance contribute to antibody pathogenicity in a murine hemophilia A model. J Thromb Haemost 16:1779-1788
Qiu, Yongzhi; Ahn, Byungwook; Sakurai, Yumiko et al. (2018) Microvasculature-on-a-chip for the long-term study of endothelial barrier dysfunction and microvascular obstruction in disease. Nat Biomed Eng 2:453-463
Sakurai, Yumiko; Hardy, Elaissa T; Ahn, Byungwook et al. (2018) A microengineered vascularized bleeding model that integrates the principal components of hemostasis. Nat Commun 9:509
Brockman, Joshua M; Blanchard, Aaron T; Pui-Yan Ma, Victor et al. (2018) Mapping the 3D orientation of piconewton integrin traction forces. Nat Methods 15:115-118
Ciciliano, Jordan C; Abbaspour, Reza; Woodall, Julia et al. (2017) Probing blood cell mechanics of hematologic processes at the single micron level. Lab Chip 17:3804-3816
Carden, Marcus A; Fay, Meredith E; Lu, Xinran et al. (2017) Extracellular fluid tonicity impacts sickle red blood cell deformability and adhesion. Blood 130:2654-2663
Qiu, Yongzhi; Tong, Sheng; Zhang, Linlin et al. (2017) Magnetic forces enable controlled drug delivery by disrupting endothelial cell-cell junctions. Nat Commun 8:15594

Showing the most recent 10 out of 46 publications